PUBLISHER: Allied Market Research | PRODUCT CODE: 1193083
PUBLISHER: Allied Market Research | PRODUCT CODE: 1193083
The global peptide therapeutics market was valued at $33,257.72 million in 2021, and is estimated to reach $64,336.12 million by 2031, growing at a CAGR of 6.8% from 2022 to 2031. A peptide is a small, chemically bound chain of amino acids, usually between two and fifty amino acids (called peptide bonds). Peptides are smaller than proteins, consisting of about 2 to 50 amino acids. Peptides employed in the therapy of diseases are known as peptide therapies. Peptide treatments replicate such roles that naturally occurring peptides can perform as hormones, growth factors, ion channel ligands, and anti-effectiveness. Given that peptides can be metabolized by the body, peptide therapeutics are thought to be generally safe and well-tolerated.The major factors that drive the growth of the peptide therapeutics market are rise in incidence of chronic diseases such as diabetes, cancer, significant development of peptide therapeutics and growth in R & D for peptide therapeutics, are the factors attributed to the growth of the peptide therapeutics market. In addition, surge in the R & D by the key players is a key trend of the market, which is expected to fuel the growth in the forecast period.
Rise in prevalence of the chronic diseases drives peptide therapeutics market. For an instance, according to the NCBI, National Center for Biotechnology Information, gastrointestinal diseases affect an estimated 60 to 70 million people annually in America and having colorectal cancer as the 2nd leading cancer diagnosed among American men and women. Thus, globally, there has been an increase in prevalence of chronic diseases. which further highlights the need for the peptide therapeutics causing the market growth.
However, poor bioavailability of peptides and high cost associated with drug development are expected to hinder the growth of the market. Conversely, growth opportunities in emerging market to suffice the consumer demands is expected to provide a great opportunity for the investors to invest in the market.
The global peptide therapeutics market is segmented on the basis of application, route of administration, distribution channel, and region. On the basis of application, the market is categorized into metabolic, oncology, gastrointestinal, neurological, cardiovascular and others. By route of administration, it is divided into oral and parenteral. By distribution channel, it is segmented into hospital pharmacies, drug store & retail pharmacies and online pharmacies. Hospital pharmacies segment is further bifurcated as private and public. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are AbbVie Inc, Amgen Inc., Bausch Health Companies Inc, Eli Lilly and company, Ever Neuro Pharma GmbH, GalaxoSmithKline plc, Novo Nordisk, Pfizer Inc, Sanofi-GSK and Takeda Pharmaceutical Company Limited.
Key Benefits For Stakeholders
By Application
By Route of administration
By Distribution Channel
By Region